Last updated on November 2017


Brief description of study


Detailed Study Description

Prospective, single arm, open-label, multicenter, post-market interventional clinical study to determine, via continuous monitoring with the Reveal XT implantable cardiac monitor (ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients once AF has been detected.

Clinical Study Identifier: TX2185

Contact Investigators or Research Sites near you

Start Over

Adriana Valencia

Baylor Scott & White Research Institute
Dallas, TX USA